COVID-19: An Opportunity to Fix Dysfunctional Biomedical R&D System
As we eagerly await a vaccine for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), we are reminded of 2003 SARS and 2012 Middle East respiratory syndrome (MERS). Even after 17 years of SARS and eight years of MERS, we do…
Read More...
Read More...